9am.health Further Expands Virtual Diabetes Clinic by Partnering With Ascensia to Add the CONTOUR®NEXT ONE Blood Glucose Meter to Its Patient Toolkit

3 years ago

Blood glucose meters allow regular at-home blood sugar checks to complement telemedicine visits, diabetes medications, lab tests, and ongoing diabetes…

SullivanCotter Enhances Provider Performance Management Technology™ User Experience for Physicians and Advanced Practice Providers

3 years ago

CHICAGO , March 23, 2022 /PRNewswire/ -- SullivanCotter, the nation's leading independent consulting firm in the assessment and development of total…

NeonMind Unveils Initial Treatment Offering at Specialty Mental Health Clinic in Mississauga

3 years ago

To Deliver Low Dose Intravenous Ketamine for Mood and Anxiety Disorders, a Recommended Treatment by Canadian Guidelines, Upon Clinic LicensingOAKVILLE,…

Mercury Medical Donates Medical Devices to Ukrainian Medical Association of North America, UMANA Foundation, to Help Save Lives

3 years ago

CLEARWATER, FL / ACCESSWIRE / March 23, 2022 / Mercury Medical responds to the plea from the Ukrainian Medical Association…

Cosmos Holdings CEO Provides Letter to Shareholders

3 years ago

CHICAGO, IL / ACCESSWIRE / March 23, 2022 / Cosmos Holdings, Inc. ("the Company") (Nasdaq:COSM), an international pharmaceutical company with…

Aytu BioPharma Announces FDA Orange Book Listing of Newly Issued Patent for Cotempla XR-ODT(R)

3 years ago

ENGLEWOOD, CO / ACCESSWIRE / March 23, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and…

BullFrog AI Enters into Licensing Agreement with Johns Hopkins University for Use of Novel Formulation of Mebendazole for Treatment of Cancer

3 years ago

GAITHERSBURG, MD / ACCESSWIRE / March 23, 2022 / BullFrog AI Holdings, Inc., a biopharmaceutical company focused on applying its…

NeonMind Announces Positive Preclinical Results Demonstrating the Efficacy of Psilocybin in Reducing Weight Gain in Obese Animal Subjects

3 years ago

Data Further Validates Psilocybin as a Drug Candidate for Obesity and Supports Development of NeonMind's Drug Programs NEO-001 and NEO-002OAKVILLE,…

Moderna Announces its COVID-19 Vaccine Phase 2/3 Study in Children 6 Months to Under 6 Years Has Successfully Met Its Primary Endpoint

3 years ago

Two 25 μg doses of mRNA-1273 in participants 6 months to under 6 years met primary endpoint with robust neutralizing…

9 Meters Biopharma Provides Business Update and Reports Financial Results for Fourth Quarter and Full Year 2021

3 years ago

RALEIGH, NC / ACCESSWIRE / March 23, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments…